Login or Sign Up
10:54 Dec 08
Rubicon Research Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Rubicon Research Ltd. Financials
Rubicon Research Ltd.
Industry Pharmaceuticals
10:54 Dec 08
Quality
0/100
Not Eligible
Valuation
4/100
Expensive Valuation
Technical
21/100
Technically Bearish
Strength
10
Weakness
0
Opportunity
1
Threats
0
24.83 %
ROE %
9.25 %
ROA %
0.00
EPS
35.10
BVPS
10.46 %
Net Profit Margin
| Mar 2023 | Mar 2024 | Mar 2025 | ||
|---|---|---|---|---|
| Net Sales | 393.52 | 853.89 | 1284.27 | |
| Operating Expenses + | 375.03 | 699.3 | 1028.33 | |
| Raw Material | 162.46 | 332.1 | 532.62 | |
| Increase Decrease in Cost | -49.24 | -53.01 | -157.22 | |
| Other Manufacturing Expense | 0 | 0 | 0 | |
| Employee Cost | 97.12 | 125.34 | 211.05 | |
| Miscellaneous Expenses | 187.59 | 463.23 | 599.92 | |
| Operating Profit | 18.49 | 154.59 | 255.94 | |
| Other Income | 25.48 | 18.5 | 11.95 | |
| Depreciation | 36.06 | 38.97 | 36.59 | |
| Interest | 18.96 | 31.26 | 36.78 | |
| Profit before tax and exceptio.. | -11.05 | 102.86 | 194.52 | |
| Exceptional Items | 0 | 0 | 0 | |
| PBT | -11.05 | 102.86 | 194.52 | |
| Provision for Taxation | 5.84 | 11.84 | 60.16 | |
| Net Profit | -16.89 | 91.01 | 134.36 | |
| NET Profit after MI | -16.89 | 91.01 | 134.36 | |
| EPS | -1.11 | 5.98 | 8.82 | |
| Operating Profit Margin (%) | 4.7 | 18.1 | 19.93 | |
| Net Profit Margin (%) | -4.29 | 10.66 | 10.46 |
Rubicon Research Ltd. Shareholding
All Data in Percentage (%)
| Promoter | - | - | - | - | - |
| FII | - | - | - | - | - |
| Public | - | - | - | - | - |
| MF | - | - | - | - | - |
| Others |
| Shareholder | Shares | Holding % |
|---|
Download Our App On:
Back
OTP sent to your mobile number. Please enter it below to verify.
Verify Email OTP
OTP sent to
Dear User, please
complete your profile!
Email ID Already Exists
Location Saved
Successfully
Email Id Verified
Successfully